CIK 0001782303 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Boundless Bio, Inc.
Sign in to watch- Ticker
- BOLD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 830751369
- Phone
- (858) 766-9912
- Business address
- 11099 NORTH TORREY PINES ROAD, SUITE 150, LA JOLLA, CA, 92037
- Open-market buys, last 90 days
- $458,375
- in 5 filings
- Open-market sales, last 90 days
- $54,351
- in 1 filing
Net +$404,024. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-25 | TANG KEVIN 10% owner | Purchase | +145,880 | $2.48 | $362K | 2,393,392 |
| 2026-06-25 | TANG KEVIN 10% owner | Purchase | +510 | $2.56 | $1K | 2,393,902 |
| 2026-06-15 | Whiting Nancy Director | Grant or award · Stock Option (right to buy) | +32,000 | 32,000 | ||
| 2026-06-15 | Lim Jonathan E Director | Grant or award · Stock Option (right to buy) | +48,000 | 48,000 | ||
| 2026-06-15 | Christensen James Director | Grant or award · Stock Option (right to buy) | +32,000 | 32,000 | ||
| 2026-06-15 | Lew Jennifer Director | Grant or award · Stock Option (right to buy) | +32,000 | 32,000 | ||
| 2026-01-23 | Oien Jessica See Remarks | Grant or award · Stock Option (right to buy) | +220,000 | 220,000 | ||
| 2026-01-23 | Hassig Christian Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +230,000 | 230,000 | ||
| 2026-01-23 | Doebele Robert Chief Medical Officer | Grant or award · Stock Option (right to buy) | +230,000 | 230,000 | ||
| 2026-01-23 | Hornby Zachary President & CEO | Grant or award · Stock Option (right to buy) | +600,000 | 600,000 | ||
| 2026-01-23 | HINKLE DAVID A See Remarks | Grant or award · Stock Option (right to buy) | +140,000 | 140,000 | ||
| 2025-06-23 | Brennan Christine Director | Grant or award · Stock Option (right to buy) | +16,000 | 16,000 | ||
| 2025-06-23 | Christensen James Director | Grant or award · Stock Option (right to buy) | +16,000 | 16,000 | ||
| 2025-06-23 | Lew Jennifer Director | Grant or award · Stock Option (right to buy) | +16,000 | 16,000 | ||
| 2025-06-23 | Lim Jonathan E Director | Grant or award · Stock Option (right to buy) | +24,000 | 24,000 | ||
| 2025-06-23 | Burow Kristina Director | Grant or award · Stock Option (right to buy) | +16,000 | 16,000 | ||
| 2025-06-23 | Whiting Nancy Director | Grant or award · Stock Option (right to buy) | +16,000 | 16,000 | ||
| 2025-02-03 | Doebele Robert Chief Medical Officer | Grant or award · Stock Option | +180,000 | 180,000 | ||
| 2025-01-22 | HINKLE DAVID A See Remarks | Grant or award · Stock Option | +65,000 | 65,000 | ||
| 2025-01-22 | Hassig Christian Chief Scientific Officer | Grant or award · Stock Option | +95,000 | 95,000 |
Page 3 of 10 · 185 trades